Sandrine Delbary-Gossart

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 4 EPO patents. Top assignees: Sanofi, Sanofi-Aventis. Active years: 2012-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandrine Delbary-Gossart. Retrieved from https://idiyas.com/inventor/sandrine-delbary-gossart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 17(Granted Patents)

Location History:

Paris, FR (2012)
Mauzac, FR (2013 - 2015)

Company Filing History:

Years Active: 2012-2015

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8957211 - (Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors (2015-02-17),

2. 8906924 - (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors (2014-12-09),

3. 8580790 - (Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors (2013-11-12),

4. 8519143 - Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors (2013-08-27),

5. 8518947 - (Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors (2013-08-27),

6. 8247404 - Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same (2012-08-21),

7. 8193190 - Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors (2012-06-05),

Title: Sandrine Delbary-Gossart: Innovator in Pharmaceutical Chemistry

Introduction

Sandrine Delbary-Gossart is a prominent inventor based in Mauzac, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 7 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents are innovative derivatives such as (heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone and (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone. These compounds are recognized for their potential use as p75 inhibitors. The disclosures detail the methods of preparation and therapeutic applications of these heterocycle-fused compounds. Additionally, she has developed (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alkanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alkanone derivatives, further expanding her contributions to the field.

Career Highlights

Sandrine has worked with notable companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in drug development.

Collaborations

Throughout her career, Sandrine has collaborated with esteemed colleagues such as Marco Baroni and Francoise Bono. These partnerships have facilitated the exchange of ideas and fostered innovation in her research endeavors.

Conclusion

Sandrine Delbary-Gossart's work exemplifies the impact of innovative thinking in pharmaceutical chemistry. Her patents and collaborations highlight her commitment to advancing therapeutic solutions.

Profile summary based on public USPTO records.